The Bennett Cancer Center's involvement in research is one of the main reasons for its accreditation at the highest level as a Teaching Hospital Cancer Program by the American College of Surgeons - a claim no other community hospital in lower Fairfield County can make.

Clinical Trials

The Bennett Cancer Center is a major research center, involved in more clinical trials than any other area hospital.

Our patients have benefited from access to leading-edge treatments that have made national news, including three major drugs (Raloxifene, Herceptin and Avastin) for breast cancer; Avastin for lung cancer; Panitumumab for colon cancer, and the WINS (Women's Intervention Nutrition Study), showing that postmenopausal women with breast cancer may improve their chances of remaining relapse-free by reducing their dietary fat intake.

6-10 percent of Bennett Cancer Center patients are enrolled in clinical trials, compared to an average of just 3 percent in many cancer centers. Involvement in clinical trials benefits patients, providing access to a wide range of new, experimental drugs without having to leave the community for treatment.

Physicians determine which patients are suitable candidates for a study by reviewing data acquired during earlier test phases, compared against a patient's past treatments and current health. Once the patient has been briefed, he or she makes the final decision about participation.

Clinical trials are currently underway for Breast, GI Rectal, GI Colorrectal, GI Gastric or Esophagogastric Junction, Myeloma, Gynocological, Urological, Lymphoma and Melanoma.

Click here to see what clinical trials are currently available at the hospital.

For more information or to make an appointment please call
1-877-233-WELL (9355).